Molecular breakthrough for complex drug targets

University of Basel research reveals structures of large molecules previously too complex for drug design

The University of Basel has used a crystalline sponge to map structures of large molecules that violate the 'rule of 5' molecular size constraints. This advance could accelerate development of therapeutics for diseases that were historically unaddressable due to molecular complexity. The work addresses a key barrier in creating drugs for complex targets, potentially expanding the range of treatable conditions through more precise molecular design.

This moves health abundance by enabling therapies for conditions previously beyond conventional drug development. The significance lies in overcoming a fundamental molecular limitation that has long restricted treatment options for complex diseases. However, the source material provides no details on specific diseases, timelines, or therapeutic applications beyond the stated mechanism. The full implications remain in the research phase with no confirmed clinical pathways.

Source: Phys.org